Skip to content
2000
Volume 21, Issue 18
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The development of novel anticancer agents with high efficiency is of great importance due to the severe anticancer scenario of the currently used drugs. Dimerization is a useful method to develop new drug candidates with a broad biological spectrum, enhanced activity and potency to overcome drug resistance. A wide variety of bis-triazole-containing compounds have been developed with improved properties compared with their parent compounds. These derivatives could inhibit tumor proliferation, invasion and metastasis, revealing their potential as putative anticancer candidates. This review covers the recent advances of bis-triazole-containing compounds as anticancer candidates, and the structure-activity relationship are also discussed to set up the direction for the design and development of bis-triazole-containing compounds with higher efficiency.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026621666210728154728
2021-07-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026621666210728154728
Loading

  • Article Type:
    Review Article
Keyword(s): 1; 2; 3-triazole; 4-triazole; Anticancer; Dimerization; Dimers; Hybrids; Structure-activity relationship
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test